Results 161 to 170 of about 185,935 (339)

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 174-185, January 2026.
Abstract Aim Metabolic bariatric surgery (MBS) improves histological endpoints in steatotic liver disease (SLD), but data on longer‐term clinical outcomes in this population are scarce. Here, we assessed the impact of MBS on hepatic and extrahepatic morbidity and mortality in individuals with SLD.
Weronika Stupalkowska, Alexander Henney, Eric G. Sheu, Uazman Alam, Daniel J. Cuthbertson   +4 more
wiley   +1 more source

Efficacy and safety of European Medicines Agency (EMA)‐approved pharmacological, endoscopic, and surgical treatments in different classes of obesity: A network meta‐analysis of randomised controlled trials for the development of the SIO (Società Italiana Obesità) Italian guidelines for the diagnosis and treatment of overweight and obesity

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 358-378, January 2026.
Abstract Aims We aimed at comparing different approved strategies (obesity management medications—OMM, endoscopic bariatric procedures—EBP, and metabolic bariatric surgery—MBS) with lifestyle intervention/placebo/no therapy (LSI/Pbo/NT) for the treatment of different BMI‐based classes of obesity (i.e., overweight—BMI: 25–29.9 kg/m2; class I—BMI: 30–34 ...
Rocco Barazzoni, Matteo Monami, Silvio Buscemi, Luca Busetto, Maurizio De Luca, Giuseppe Navarra, Benedetta Ragghianti, Giovanni Antonio Silverii, Amanda Belluzzi, Edoardo Mannucci, Paolo Sbraccia   +10 more
wiley   +1 more source

Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 529-538, January 2026.
Abstract Aims This study examined rates of metabolic/bariatric surgery (MBS) among adults with type 2 diabetes and obesity (T2D + O). The study also compared glucose‐lowering medication (GLM) use, costs, comorbidities and medical events for individuals with T2D + O who underwent MBS (cases) to those who did not have MBS (controls).
Kristina S. Boye, Lisa M. Neff, Magaly Perez‐Nieves, Maureen J. Lage, K. Karthik Chivukula   +4 more
wiley   +1 more source

Longitudinal sleeve gastrectomy: current perspectives

Open Access Surgery, 2014
Emanuele Soricelli, Giovanni Casella, Giorgio Di Rocco, Adriano Redler, Nicola BassoDepartment of Surgical Sciences, Policlinico Umberto I, Sapienza, University of Rome, ItalyAbstract: Since the early 2000s, laparoscopic sleeve gastrectomy has ...
Soricelli E, Casella G, Di Rocco G, Redler A, Basso N   +4 more
doaj  

A Systematic Review of Staple-Line Reinforcement in Laparoscopic Sleeve Gastrectomy [PDF]

, 2013
Jean Knapps, M. Ghanem, John M. Clements, Aziz M. Merchant   +3 more
openalex   +1 more source

MRI Analysis of Cardiac Fat, Abdominal Adiposity and Cardiac Function After Vertical Sleeve Gastrectomy in Youth With Type 2 Diabetes

Pediatric Obesity, Volume 21, Issue 1, January 2026.
ABSTRACT Background Adolescents with youth‐onset type 2 diabetes (YO‐T2D) have an increased risk for cardiometabolic complications. The impact of vertical sleeve gastrectomy (VSG) on fat distribution and cardiac morphology/function in YO‐T2D is unknown.
Tyler J. Dobbs, Linnea Gutierrez, Houchun Harry Hu, Kendall S. Hunter, Brian Fonseca, Lorna Browne, David Winter, Melanie G. Cree, Laura Pyle, Jonathan L. Hills‐Dunlap, Jane E. B. Reusch, Megan M. Kelsey, Thomas H. Inge, Petter Bjornstad, Kristen J. Nadeau   +14 more
wiley   +1 more source

Sleeve Gastrectomy and Pancreatic Omentoplasty improve β-cell status in Rats by increasing VEGF, PDX1, islet of Langerhans area, and β-cell count

JLUMHS
OBJECTIVE: To analyze the effect of sleeve gastrectomy and pancreatic omentoplasty on pancreatic β cell status by evaluating the levels of PDX1 and VEGF. METHODOLOGY: This experimental animal research was done with a post-test-only control design.
Abdul Mughni, Reno Rudiman, Tjokorda Gde Dalem Pemayun, Bella Renata, Endang Mahati, Suharyo Hadisaputro, Ignatius Riwanto   +6 more
doaj   +1 more source

Gastrektomia bertikala obesitate morbidoan. Sindrome metabolikoan duen eragina. [PDF]

, 2017
[EUS] Sarrera: azken urteetan mundu mailan obesitatearen prebalentzia areagotzen ari da, morbi-mortalitatea areagotzen duen zenbait patologiarekin erlazionaturik egonez.
Villalabeitia Ateca, Ibabe
core  

Correction to: Establishing a Reproducible Murine Animal Model of Single Anastomosis Duodenoileal Bypass with Sleeve Gastrectomy (SADl-S) [PDF]

, 2018
L. Montana, Mylene Lamon, Christophe Barrat, Boris Hansel, Chr̀istophe Magnan, Konstantinos Arapis   +5 more
openalex   +1 more source

Topical Volumizing Cream Improves Facial Volume and Skin Health in Adults With Rapid Weight Loss From Pharmacologic (GLP‐1/GIP Agonists), Surgical, or Behavioral Interventions

Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background GLP‐1 receptor agonists (GLP‐1) and dual GLP‐1/gastric inhibitory polypeptide (GIP) agonists emerged in recent years to promote weight loss. By reducing subcutaneous fat, collagen, and overall structural support of the skin, rapid weight loss can lead to visual face aging.
Nhi Nguyen, Alejandra Aguilar, Nasima Afzal, Andy Lee, Wardah Akram, Minh N. Duong, Raja K. Sivamani   +6 more
wiley   +1 more source